FDA Adverse Event Injury Summary report: N

AVANTA FLUID MANAGEMENT INJECTION SYSTEM

MDR report key: 2162146 · Received July 7, 2011

Report

Report Number
2520313-2011-00018
Event Type
Injury
Date Received
July 7, 2011
Date of Event
June 20, 2011
Report Date
June 20, 2011
Manufacturer
MEDRAD
Product Code
DXT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A MEDRAD SERVICE ENGINEER PERFORMED A SYSTEM SERVICE CHECK OF THE AVANTA FLUID MANAGEMENT INJECTION SYSTEM ON (B)(4), 2011 AND THE UNIT WAS FOUND TO BE OPERATING TO SPECIFICATION. THE SITE CONTINUED TO USE THE INJECTOR AFTER THE REPORTED EVENT - NO FURTHER ISSUES WERE REPORTED. MEDRAD QUALITY ASSURANCE PRODUCT ANALYSIS EXAMINED THE PRODUCTS THAT WERE RETURNED BY THE SITE, WHICH CONSISTED OF THE FOLLOWING: ONE MULTI-PATIENT DISPOSABLE SET (MPAT) WITH A 500ML BAG OF HEPARIN ATTACHED TO THE SALINE SIDE, ONE SINGLE-PATIENT DISPOSABLE SET (SPAT) WITH A NON-MEDRAD HEMODYNAMIC TRANSDUCER ATTACHED, A HAND CONTROLLER, AND A SYRINGE. FUNCTIONAL TESTING OF THE RETURNED PRODUCTS CONFIRMED THAT THE DISPOSABLES PERFORMED TO SPECIFICATION WITH NO PROBLEMS FOUND. ADDITIONAL APPLICATIONS TRAINING WAS OFFERED TO THE SITE; HOWEVER, THEY DECLINED.

Description of Event or Problem · 1

THE SITE REPORTED THE FOLLOWING: A PATIENT WITH AN ADMITTING DIAGNOSIS OF A POSITIVE STRESS TEST UNDERWENT A DIAGNOSTIC CARDIAC CATHETERIZATION. FOLLOWING THE FIRST INJECTION, AIR WAS VISUALIZED IN THE LEFT ANTERIOR DESCENDING ARTERY. THE AMOUNT OF AIR THAT WAS INJECTED INTO THE PATIENT IS UNKNOWN. ST SEGMENT ELEVATION WAS NOTED ON THE ECG MONITOR. THE PATIENT REQUIRED MEDICAL INTERVENTION, WHICH INCLUDED ATROPINE, EPINEPHRINE AND AN INSERTION OF AN INTRA-AORTIC BALLOON PUMP. THE PATIENT WAS ADMITTED TO THE INTENSIVE CARE UNIT AND DISCHARGED TO HOME LATER THAT WEEK. THE PATIENT IS REPORTEDLY DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AVANTA FLUID MANAGEMENT INJECTION SYSTEM ANGIOGRAPHIC INJECTOR DXT MEDRAD AVA 500 TABL

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention AVANTA SINGLE-PATIENT DISPOSABLE SET| AVANTA MULTI-PATIENT DISPOSABLE SET